U
DSCI

UBS’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

UBS’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$180K Buy
21,529
+3,170
+17% +$29.4K ﹤0.01% 5299
2014
Q2 		$213K Buy
18,359
+4,124
+29% +$42.3K ﹤0.01% 5083
2014
Q1 		$181K Sell
14,235
-59
-0.4% -$763 ﹤0.01% 5310
2013
Q4 		$155K Sell
14,294
-422
-3% -$4.9K ﹤0.01% 5569
2013
Q3 		$183K Buy
14,716
+1,672
+13% +$23.1K ﹤0.01% 5295
2013
Q2 		$174K Buy
+13,044
New +$168K ﹤0.01% 5258

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

UBS's DSCI Position: Q3 2014 in Review

UBS increased its Derma Sciences, Inc. Common Stock (DE) (DSCI) stake by 17% in Q3 2014, buying an estimated $29.4K and bringing the position to 21,529 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #5299.

UBS first reported a position in DSCI in Q2 2013 and has held it in 6 quarters since. The position peaked at $213K in Q2 2014. 70 funds tracked by Wall St. Rank hold DSCI as of Q3 2014.

  • UBS held 21,529 shares of Derma Sciences, Inc. Common Stock (DE) worth $180K as of Q3 2014.
  • UBS bought 3,170 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2014, an estimated $29.4K.
  • Derma Sciences, Inc. Common Stock (DE) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5299 holding.
  • UBS first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and has held it in 6 quarters since.
  • UBS's Derma Sciences, Inc. Common Stock (DE) position peaked at $213K in Q2 2014.
  • 70 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.